# Cerephex

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cerephex

- Industry: Medical Devices & Equipment
- Headquarters: US
- Website: www.cerephex.com
- Total disclosed funding: $5.9M
- Latest round: Series A (Oct 12, 2012)
- Investors on record: 3

## About

Cerephex Corp is a technology company specializing in innovative solutions that enhance operational efficiency and improve user experiences across various sectors.Cerephex Corp provides technology solutions aimed at streamlining operations. Founded in the US, the company has undergone strategic pivots to focus on its core software applications. They have secured funding primarily through their Series A round, raising USD 5.90 mn from investors including H.I.G. BioHealth Partners, Versant Ventures, and CHV Ventures on October 12, 2012.Cerephex Corp specializes in delivering technology solutions that enhance operational efficiency and user experience. Their offerings include advanced software applications for real-time data analytics, project management, and customer relationship management. These solutions target critical challenges in industries such as logistics, healthcare, and finance, supporting operational teams, project managers, and executives in making informed decisions.The company generates revenue through a subscription-based model and direct sales partnerships. Clients typically enter annual subscription agreements for access to their software solutions, with tiered pricing based on features. Their flagship product, featuring advanced analytics, is available at a premium rate, and they also collaborate with resellers to broaden their market reach.Cerephex Corp plans to expand its offerings with new products focusing on enhanced analytics capabilities, aiming for a launch in the next fiscal year. The company is targeting growth in North American and European markets by the end of 2023. The recent Series A funding of USD 5.90 mn will support these initiatives, enabling product development and market expansion efforts.

## Funding rounds

- Series A, Oct 12, 2012, $5.9M — Versant Ventures, H.I.G. BioHealth Partners, CHV Ventures

## Investors

- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A
- H.I.G. BioHealth Partners (https://capitalatlas.ai/funds/h-i-g-biohealth-partners) — Series A
- CHV Ventures (https://capitalatlas.ai/funds/chv-ventures) — Series A